Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices

Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015

Optimizing survival in advanced prostate cancer: Welcome and introduction

Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Welcome and introduction ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015

Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to optimise survival

Prof Karim Fizazi - Institut Gustave Roussy, Paris, France
Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to optimise survival ( Prof Karim Fizazi - Institut Gustave Roussy, Paris, France )
29 Jan 2015

Optimizing Survival in Advanced Prostate Cancer: Conclusion

Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing Survival in Advanced Prostate Cancer: Conclusion ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015

Cancer cell models for improved therapies

Dr Mathew Garnett, Wellcome Trust Sanger Institute, Cambridge, UK
Cancer cell models for improved therapies ( Dr Mathew Garnett, Wellcome Trust Sanger Institute, Cambridge, UK )
6 Jan 2015

UICC 2014 conference report

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
UICC 2014 conference report ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
18 Dec 2014

Comment: SABCS 2014 Highlights

Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: SABCS 2014 Highlights ( Prof Kent Osborne -  Baylor College of Medicine, Houston, USA )
16 Dec 2014

Comment: Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ

Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ ( Prof Kent Osborne -  Baylor College of Medicine, Houston, USA )
16 Dec 2014

CLL at ASH 2014: Expert discussion

Prof John Gribben and Prof Stephan Stilgenbauer
CLL at ASH 2014: Expert discussion ( Prof John Gribben and Prof Stephan Stilgenbauer )
12 Dec 2014

Best of ASH 2014

Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele
Best of ASH 2014 ( Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele )
8 Dec 2014

ASH 2014: Highlights in CLL from ASH 2014

Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger
ASH 2014: Highlights in CLL from ASH 2014 ( Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger )
8 Dec 2014

ASH 2014: Highlights in mantle cell lymphoma

Prof Steven Le Gouill and Prof Simon Rule
ASH 2014: Highlights in mantle cell lymphoma ( Prof Steven Le Gouill and Prof Simon Rule )
8 Dec 2014